Vida Medicarez Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 08-12-2024
- Paid Up Capital ₹ 1.59 M
as on 08-12-2024
- Company Age 20 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 7.50 Cr
as on 08-12-2024
- Revenue -100.00%
(FY 2022)
- Profit -2729.75%
(FY 2022)
- Ebitda -1042.43%
(FY 2022)
- Net Worth -106.38%
(FY 2022)
- Total Assets -96.98%
(FY 2022)
About Vida Medicarez
- CIN/LLPIN
U24230MH2004PLC148151
- Company No.
148151
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Aug 2004
- Date of AGM
20 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vida Medicarez?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhusudan Ruia  | Director | 20-Aug-2004 | Current |
| Raghav Ruia | Director | 03-Mar-2020 | Current |
| Mahendra Kumawat | Director | 17-Sep-2020 | Current |
Financial Performance of Vida Medicarez.
Vida Medicarez Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 2729.75% decrease in profit. The company's net worth observed a substantial decline by a decrease of 106.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vida Medicarez?
In 2022, Vida Medicarez had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Agio Pharmaceuticals LimitedActive 32 years 11 monthsMadhusudan Ruia, Raghav Ruia and 1 more are mutual person
Revive Pharmaceuticals Private LimitedActive 28 years 11 monthsMadhusudan Ruia and Mahendra Kumawat are mutual person
- Bhakti Enterprises LimitedActive 17 years 3 months
Madhusudan Ruia, Raghav Ruia and 1 more are mutual person
- Kimaya Property Private LimitedActive 15 years 4 months
Madhusudan Ruia and Mahendra Kumawat are mutual person
- Genome Pharmaceuticals And Chemicals Private LimitedActive 30 years 5 months
Mahendra Kumawat is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Oriental Bank Of Commerce Creation Date: 27 Jun 2012 | ₹7.50 Cr | Satisfied |
How Many Employees Work at Vida Medicarez?
Unlock and access historical data on people associated with Vida Medicarez, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vida Medicarez, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vida Medicarez's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
